TY - JOUR
T1 - Impact of COVID-19 Pandemic on Cardiovascular Testing in Asia
T2 - The IAEA INCAPS-COVID Study
AU - INCAPS-COVID Investigators Group
AU - Kudo, Takashi
AU - Lahey, Ryan
AU - Hirschfeld, Cole B.
AU - Williams, Michelle C.
AU - Lu, Bin
AU - Alasnag, Mirvat
AU - Bhatia, Mona
AU - Henry Bom, Hee Seung
AU - Dautov, Tairkhan
AU - Fazel, Reza
AU - Karthikeyan, Ganesan
AU - Keng, Felix Y.J.
AU - Rubinshtein, Ronen
AU - Better, Nathan
AU - Cerci, Rodrigo Julio
AU - Dorbala, Sharmila
AU - Raggi, Paolo
AU - Shaw, Leslee J.
AU - Villines, Todd C.
AU - Vitola, João V.
AU - Choi, Andrew D.
AU - Malkovskiy, Eli
AU - Goebel, Benjamin
AU - Cohen, Yosef A.
AU - Randazzo, Michael
AU - Pascual, Thomas N.B.
AU - Pynda, Yaroslav
AU - Dondi, Maurizio
AU - Paez, Diana
AU - Einstein, Andrew J.
AU - Cerci, Rodrigo
AU - Vitola, Joao V.
AU - Hinterleitner, Gerd
AU - Lu, Yao
AU - Morozova, Olga
AU - Xu, Zhuoran
AU - Cohen, Yosef
AU - Choi, Andrew
AU - Lopez-Mattei, Juan
AU - Parwani, Purvi
AU - Nasery, Mohammad Nawaz
AU - Goda, Artan
AU - Shirka, Ervina
AU - Benlabgaa, Rabie
AU - Bouyoucef, Salah
AU - Medjahedi, Abdelkader
AU - Nailli, Qais
AU - Agolti, Mariela
AU - Aguero, Roberto Nicolas
AU - Al Dhuhli, Humoud
N1 - Publisher Copyright:
© 2021 The Authors
PY - 2021/9
Y1 - 2021/9
N2 - Background: The coronavirus disease-2019 (COVID-19) pandemic significantly affected management of cardiovascular disease around the world. The effect of the pandemic on volume of cardiovascular diagnostic procedures is not known. Objectives: This study sought to evaluate the effects of the early phase of the COVID-19 pandemic on cardiovascular diagnostic procedures and safety practices in Asia. Methods: The International Atomic Energy Agency conducted a worldwide survey to assess changes in cardiovascular procedure volume and safety practices caused by COVID-19. Testing volumes were reported for March 2020 and April 2020 and were compared to those from March 2019. Data from 180 centers across 33 Asian countries were grouped into 4 subregions for comparison. Results: Procedure volumes decreased by 47% from March 2019 to March 2020, showing recovery from March 2020 to April 2020 in Eastern Asia, particularly in China. The majority of centers cancelled outpatient activities and increased time per study. Practice changes included implementing physical distancing and restricting visitors. Although COVID testing was not commonly performed, it was conducted in one-third of facilities in Eastern Asia. The most severe reductions in procedure volumes were observed in lower-income countries, where volumes decreased 81% from March 2019 to April 2020. Conclusions: The COVID-19 pandemic in Asia caused significant reductions in cardiovascular diagnostic procedures, particularly in low-income countries. Further studies on effects of COVID-19 on cardiovascular outcomes and changes in care delivery are warranted.
AB - Background: The coronavirus disease-2019 (COVID-19) pandemic significantly affected management of cardiovascular disease around the world. The effect of the pandemic on volume of cardiovascular diagnostic procedures is not known. Objectives: This study sought to evaluate the effects of the early phase of the COVID-19 pandemic on cardiovascular diagnostic procedures and safety practices in Asia. Methods: The International Atomic Energy Agency conducted a worldwide survey to assess changes in cardiovascular procedure volume and safety practices caused by COVID-19. Testing volumes were reported for March 2020 and April 2020 and were compared to those from March 2019. Data from 180 centers across 33 Asian countries were grouped into 4 subregions for comparison. Results: Procedure volumes decreased by 47% from March 2019 to March 2020, showing recovery from March 2020 to April 2020 in Eastern Asia, particularly in China. The majority of centers cancelled outpatient activities and increased time per study. Practice changes included implementing physical distancing and restricting visitors. Although COVID testing was not commonly performed, it was conducted in one-third of facilities in Eastern Asia. The most severe reductions in procedure volumes were observed in lower-income countries, where volumes decreased 81% from March 2019 to April 2020. Conclusions: The COVID-19 pandemic in Asia caused significant reductions in cardiovascular diagnostic procedures, particularly in low-income countries. Further studies on effects of COVID-19 on cardiovascular outcomes and changes in care delivery are warranted.
KW - COVID-19
KW - cardiac testing
KW - cardiovascular disease
KW - coronavirus
KW - global health
UR - http://www.scopus.com/inward/record.url?scp=85126284305&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85126284305&partnerID=8YFLogxK
U2 - 10.1016/j.jacasi.2021.06.002
DO - 10.1016/j.jacasi.2021.06.002
M3 - Article
AN - SCOPUS:85126284305
SN - 2772-3747
VL - 1
SP - 187
EP - 199
JO - JACC: Asia
JF - JACC: Asia
IS - 2
ER -
